Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy

Publisher： Karger

E-ISSN： 1423-0232|88|3|180-188

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.3, 2014-11, pp. : 180-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study

Oncology, Vol. 82, Iss. 4, 2012-04 ,pp. : 218-227

Karger

Access to resources Recommend Favorite

First-Line Herceptin^® Monotherapy in Metastatic Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX

Oncology, Vol. 90, Iss. 5, 2016-04 ,pp. : 261-266

Karger

Access to resources Recommend Favorite

ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy

Oncology, Vol. 83, Iss. 4, 2012-08 ,pp. : 218-227

Karger

Access to resources Recommend Favorite